Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

PI3K p110beta/delta Inhibitor KA2237

Known as: KA 2237, KA2237, PI3 Kinase b/d Inhibitor KA2237 
A dual selective inhibitor of the beta and delta isoforms of the 110 kDa catalytic subunit of class I phosphoinositide-3 kinase (PI3K-beta/delta… Expand
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
Background: Mantle cell lymphoma (MCL) accounts for 6% of all non-Hodgkin lymphoma and is a therapeutic challenge… Expand
Is this relevant?
2016
2016
Two de novo-designed classes of orally-active immunotherapeutics - selectively targeting the PI3K-p110β/p110δ and HDAC6 enzymes… Expand
Is this relevant?
2016
2016
The phosphatidylinositide 3-kinases (PI3Ks) have emerged as important therapeutic targets for the treatment of solid and… Expand
Is this relevant?